skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Prodrugs based on phospholipid-nucleoside conjugates

Patent ·
OSTI ID:865159
 [1]
  1. Naperville, IL
+ Show Author Affiliations

The invention relates to the production of a single diastereomeric form of a phospholipid araC conjugate as a prodrug.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
DOE Contract Number:
W-31109-ENG-38
Assignee:
United States of America as represented by Department of Energy (Washington, DC)
Patent Number(s):
US 4471113
OSTI ID:
865159
Country of Publication:
United States
Language:
English

Similar Records

Prodrugs based on phospholipid-nucleoside conjugates
Patent · Tue Sep 11 00:00:00 EDT 1984 · OSTI ID:865159
New prodrugs based on phospholipid-nucleoside conjugates
Patent · Wed Feb 03 00:00:00 EST 1982 · OSTI ID:865159
Phospholipid-nucleoside conjugates. 5. The interaction of selected 1-. beta. -D-arabinofuranosylcytosine-5'-diphosphate-L-1,2-diacylglycerols with serum lipoproteins
Journal Article · Mon Oct 31 00:00:00 EST 1983 · Biochem. Biophys. Res. Commun.; (United States) · OSTI ID:865159
+1 more

Related Subjects

prodrugs
based
phospholipid-nucleoside
conjugates
relates
production
single
diastereomeric
form
phospholipid
arac
conjugate
prodrug
diastereomeric form
/999/